Tradestie Institutional Equity Comparison Engine

SHPH vs OKYO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SHPH Overall Edge

SHPH Captures Institutional Edge (2โ€“0 Pillars ยท 3โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Shuttle Pharmaceuticals Holdings, Inc. Common Stock (SHPH) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, SHPH trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus OKYO at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, SHPH sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against OKYO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
SHPH N/M vs OKYO N/M Fwd P/E
Growth & Margin Winner SHPH
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner SHPH
1Y +76.3% vs -47.0% ยท 52W Pos 54% vs 3%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
SHPH NASDAQ
Shuttle Pharmaceuticals Holdings, Inc. Common Stock
Pharmaceutical Preparations
$3.49
-10.51% 1D
Market Cap $17.6M
1M Return -24.3%
1Y Return +76.26%
Forward P/E N/M
Unified AI Score
48.3 / 100 HOLD
Tech 38.0 Fund 47.0 Flow 50.0 Mom 46.0
OKYO NASDAQ
OKYO Pharma Limited Ordinary Shares
Biological Products, (No Diagnostic Substances)
$1.07
-7.76% 1D
Market Cap $62.7M
1M Return -27.21%
1Y Return -47.03%
Forward P/E N/M
Unified AI Score
42.8 / 100 HOLD
Tech 38.0 Fund 54.0 Flow 50.0 Mom 45.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SHPH +76.26% OKYO -47.03% Spread: +123.29 pp (SHPH Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
SHPH TTM Op. Margin: 0.0% OKYO TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SHPH vs OKYO. Trailing 12-month operating profitability (SHPH 0.0% vs OKYO 0.0%) and valuation multiples (SHPH N/M vs OKYO N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SHPH (3) vs OKYO (2)
Institutional Metric SHPH OKYO Criterion Row Winner
Market Capitalization Scale $17.6M $62.7M Larger Scale OKYO
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +0.0% Higher Growth Tie
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -90.0% -263.8% Higher ROE SHPH
52-Week Range Position Momentum 54% ($0โ€“$6) 3% ($1โ€“$3) Stronger Trend SHPH
Beta / 30D Volatility Risk Regime 9.23ฮฒ ยท 88% Vol 1.00ฮฒ ยท 76% Vol Lower Realized Risk OKYO
Unified Institutional Score Composite Signal 48.3 / 100 (HOLD) 42.8 / 100 (HOLD) Higher Composite SHPH

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SHPH vs OKYO Buy Guide
SHPH UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live SHPH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
OKYO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live OKYO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SHPH nor OKYO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.